Literature DB >> 15566907

Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area.

Philip J Patel1, Richard J Keating, Bernard J Gersh, David O Hodge, Stephen C Hammill, Win-Kuang Shen.   

Abstract

This study examined the prognostic significance of atrial fibrillation (AF) in a community-based cohort. AF, the most common cardiac dysrhythmia, frequently occurs in the presence of concomitant medical illness. Population-based studies have associated AF with excess mortality, and this risk of death is independent of concomitant cardiovascular disease. The effect of noncardiovascular medical illnesses on mortality in patients who have AF has not been determined. We examined a community-based cohort of 390 residents of Olmsted County, Minnesota, who had newly diagnosed AF; patients were identified retrospectively but followed prospectively. The cohort included all patients who had electrocardiographically proved first-onset AF; patients were not excluded on the basis of medical illness. Mean age of the cohort was 73 +/- 14 years (56% were men). Mean follow-up was 2.7 +/- 1.7 years. Onset of AF frequently occurred during hospitalization (78%). One hundred sixty-six deaths occurred, a death rate significantly higher than expected for the cohort. Most deaths had a noncardiovascular cause. This trend was maintained for patients who had no previous cardiovascular disease and for those who had a cardiovascular diagnosis at the time AF was diagnosed. AF is observed frequently among hospitalized patients who are medically ill. The survival rate of these patients is low, but AF may be only a minor component of the excess mortality.

Entities:  

Mesh:

Year:  2004        PMID: 15566907     DOI: 10.1016/j.amjcard.2004.08.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

2.  Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications.

Authors:  Miriam Shteinshnaider; Dorit Almoznino-Sarafian; Irena Alon; Irma Tzur; Sylvia Berman; Natan Cohen; Oleg Gorelik
Journal:  J Atr Fibrillation       Date:  2012-06-15

3.  Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.

Authors:  L Rejnmark; P Vestergaard; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-11-09       Impact factor: 4.507

4.  Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up.

Authors:  Kai Sonne; Dimpi Patel; Prasant Mohanty; Luciana Armaganijan; Lucie Riedlbauchova; Moataz El-Ali; Luigi Di Biase; Preeti Venkatraman; Mazen Shaheen; Marketa Kozeluhova; Robert Schweikert; J David Burkhardt; Robert Canby; Oussama Wazni; Walid Saliba; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2009-11       Impact factor: 1.900

5.  First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation.

Authors:  Stefano Guzzetti; Giorgio Costantino; Alessandra Vernocchi; Simona Sada; Camilla Fundarò
Journal:  Intern Emerg Med       Date:  2008-03-05       Impact factor: 3.397

6.  Newly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular events.

Authors:  Chen-Yu Li; Chia-Pin Lin; Yu-Sheng Lin; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

7.  Identifying predictors of cumulative healthcare costs in incident atrial fibrillation: a population-based study.

Authors:  Maria C Bennell; Feng Qiu; Andrew Micieli; Dennis T Ko; Paul Dorian; Clare L Atzema; Sheldon M Singh; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2015-04-23       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.